A comprehensive view of Liver/Kidney/Bladder Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer investing US$25M in biotech firm Akero Therapeutics to fund development of injectable liver drug efruxifermin to treat cirrhotic, cirrhotic non-alcoholic steatohepatitis; deal gives Pfizer 6.7% of Akero’s common stock
Published: June 22, 2022 by SeeNews Pharmaceuticals
Kibow Pharmaceuticals recruiting 630 patients for Phase 2b global clinical trial of oral US-APR2020 live biotherapeutic to treat chronic kidney disease; CKD treatment for US Medicare patients cost US$87.2B in 2019 according to CDC data
Published: May 18, 2022 by PR Newswire
FDA approves Hologic’s Aptima CMV Quant assay for use with Hologic’s automated Panther system for solid organ, stem cell transplant patients; test is firm's first post-transplant pathogen detection test in US, joins tests for HIV-1, hepatitis C and B
Published: May 12, 2022 by Business Wire
Low levels of vitamin K may impact some cognitive abilities in the elderly including orientation, calculation skills, language; vitamin K linked to bone, heart, kidney, lung, eye, nerve, cellular health: study
Published: May 12, 2022 by Nutra Ingredients
Everest Rehabilitation Hospitals opens US$24M, 40,000-square-foot, 36-bed physical rehabilitation hospital in Liberty Township, Ohio; facility offers dialysis, pharmacy, aqua therapy, physical therapy
Published: April 19, 2022 by Rehab Management

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count